Enterprise Europe Network

Israeli independent active pharmaceutical ingredients (API) company of choice for pharmaceutical industry leaders is looking for subcontracting, manufacturing, commercial agency or distribution agreements

Country of origin:
Country: 
ISRAEL
Opportunity:
External Id: 
BOIL20200202001
Published
04/02/2020
Last update
04/02/2020
Expiration date
04/02/2021

Keywords

Partner keyword: 
Pharmaceutics
Inorganic Chemistry
Organic Chemistry
Pharmaceutical Products / Drugs
Biochemistry / Biophysics
Pharmaceuticals/fine chemicals
Other speciality chemicals
Manufacture of basic pharmaceutical products
EXPRESS YOUR INTEREST

Summary

Summary: 
The independent API company of choice for pharmaceutical industry leaders is located in a special ecological industrial zone in southern Israel. The company offers a variety of tailor-made solutions necessary to manufacture premium APIs. It is looking for additional partners to develop and market products globally either through outsourcing or manufacturing agreements. Also a commercial agency or distribution agreement would be considered to expand sales to markets not already exhausted.

Description

Description: 

For over 33 years the world-class independent developer and manufacturer of differentiated Active Pharmaceutical Ingredients. A trusted name in the pharmaceutical industry, is attentive to be a partner that is in tune with the results required to better support the requirements of its' customers and partner(s). Founded in Israel in 1987, serving more than 250 customers in 50 countries, it employs a highly skilled team with all the expertise you require to advance products to market, now, and well into the future. Our cGMP-compliant facility is a first-class operation with over 30 years of exceptional regulatory track record with leading global authorities such as USFDA, EUEMA, PMDA, TGA, KFDA, ANVISA and COFEPRIS, while meeting the highest safety and environmental responsibility standards. The company values its experts in complex chemistry, innovative process development, crystalline forms and particle design and offer customized solutions to meet individual customer requirements including full spectrum API CDMO services from pre-clinical grams to multi-ton commercial scale.
The company is looking for a commercial agent or pharmaceutical distributor to acquire new markets to the company to add to the existing markets. The company is interested also in a manufacturing agreement with companies in the pharmaceutical industry who are seeking development of APIs. Additionally, an outsourcing agreement can be made for companies in the same industry who are seeking to outsource their production.

Advantages & innovations

Cooperation plus value: 
A world-class developer and manufacturer of high-quality differentiated APIs (Active Pharmaceutical Ingredients) for branded and generic pharmaceutical industries. The presence of the firm in the international market is available with 250 customers in over 50 countries, which is continuing to grow. The company has over 33 years of an exceptional regulatory track record with authorities (USFDA, EU-EMA, PMDA, TGA, KFDA, ANVISA and COFEPRIS). The company's manufacturing facility has a wide range of multi-purpose capabilities from lab-scale (grams) to pilot scale (kgs) and up to muli-ton commercial quantities. More than 250 metric tons of API produced every year in this facility. Other advantages are as follows: Customer oriented company which strives to be on the same wavelength with its customers and partners, always in tune with the results required to support your needs. Strong expertise in complex chemistry, innovative process development, crystalline forms and particle design Leading R&D capabilities and strong regulatory expertise – 198 DMFs (Drug Master File) worldwide API CDMO (contract developing manufacturing organization) services from pre-clinical grams to multi ton commercial scale Customized solutions to meet individual customer requirements Creative business models to get to market, including co-development partnerships. Long heritage of excellence, and global leadership in select molecules

Stage of development

Cooperation stage dev stage: 
Already on the market

Partner sought

Cooperation area: 
The Israeli manufacture is seeking for an agent or distributor active in the pharmaceutical industry and with a successful background to represent the company's active portfolio of active APIs to targeted markets. The aim is to acquire new markets where the company is not active, and to expand the sales of the company. The target markets will be discussed further with inquirers. The Israeli company is seeking a manufacturing agreement for APIs that a pharmaceutical company may require for their clinical development programs. The manufacture also offers custom development of a certain API to meet the desired outcome and need of the end product. The Israeli company is seeking a outsourcing agreement for pharmaceutical companies currently manufacturing APIs, who are looking to outsource their production of existing API manufacturing process.

Type and size

Cooperation task: 
SME 11-50,SME <10,>500 MNE,251-500,SME 51-250,>500